51 results
Posted on 29.04.2020
Maximising the potential of diagnostic information in heart failure care
Covid-19 has proven a seismic event for our societies, and it is easy to forget that the pandemic will not dominate the debate on healthcare forever. Yet by any rational measure, efforts to manage long-term conditions will continue to be responsible for the majority of healthcare costs into the future. Heart failure (HF) is, and […]
Posted on 26.07.2017
The role of medtech in fighting hepatitis
International efforts to tackle the hepatitis pandemic have reached new heights, especially in the past year since the 69th World Health Assembly (WHA) endorsed the Global Health Sector Strategy (GHSS) on viral hepatitis 2016–2021. It is estimated that some 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus […]
Posted on 06.04.2016
Diabetes takes centres stage on World Health Day 2016
This April 7th marks World Health Day (WHD). The first World Health Assembly, held by the World Health Organization (WHO) in 1948, declared that WHD would be celebrated on this date from 1950 onwards. I am pleased to see that for the first time ever, WHO has chosen diabetes as its theme for WHD in […]
Posted on 05.02.2016
Why diagnostics is important in dealing with the Zika threat
In the last few weeks we have seen the emergence of a new global public health threat, the Zika Virus (ZIKV). Both the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC) are monitoring the spread of the Zika, a mosquito borne arbovirus. The WHO recently declared the diseases linked […]
Posted on 18.11.2014
How can we approach this era of superbugs and healthcare-associated infections
Today is European Antibiotic Awareness Day. Tackling the era of superbugs should be a team sport. Physicians, companies, foundations and the MedTech industry all want to play their part.
Posted on 29.07.2014
Superbugs: “The physician community needs to get its act together”
The WHO has been raising the ‘threat level’ on this issue progressively each year for the last decade, with individual disease reports highlighting the emerging threat of antimicrobial resistance (AMR). This year’s report however highlights this pandemic like never before, demonstrating it’s global nature and its profound impact on health and economics. I’m a cardiologist and the report speaks to me – actually it screams out loud: “We need to get our act together”.